Zimmer Biomet (ZBH) Q4 Earnings: Revenue Up 9.9% Exps $2.22B, EPS $2.40 vs $2.00B, $2.40/share

Zimmer Biomet (NYSE:ZBH) will report Q4 earnings before market open on February 06, 2026. The company is expected to post revenue of $2.22 billion, up 9.9% year-on-year, and adjusted earnings of $2.40 per share, compared to $2.00 billion revenue and $2.40/share guidance last quarter. Revenue is in line with analyst estimates, while EPS is seen narrowly exceeding guidance. Last quarter’s results met revenue expectations with $2.00 billion, up 9.7% YoY. Analysts have averaged a price target of $102.74 for ZBH, versus its current share price of $89.92.